<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03254160</url>
  </required_header>
  <id_info>
    <org_study_id>DNS-3379-201</org_study_id>
    <nct_id>NCT03254160</nct_id>
  </id_info>
  <brief_title>DNS-3379 vs. Placebo in Stroke Rehabilitation</brief_title>
  <acronym>SPIRIT</acronym>
  <official_title>A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 42-Day Treatment Study to Evaluate the Effect of DNS-3379 on Upper Extremity Motor Function Following Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dart NeuroScience, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dart NeuroScience, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day
      treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate
      the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic
      stroke.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Administrative
  </why_stopped>
  <start_date type="Actual">November 13, 2017</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Assessment of Upper Extremity Motor Function, Parts A-D</measure>
    <time_frame>42-days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Type and incidence of treatment emergent adverse events</measure>
    <time_frame>84-days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Laboratory Assessments</measure>
    <time_frame>84-days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital signs and 12-lead ECG</measure>
    <time_frame>84-days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Assessment of Upper Extremity Motor Function (Parts A-D)</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nine-Hole Peg Test</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in weight</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Columbia Suicide Severity Rating Scale</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Two-Minute Walk Test</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-5L</measure>
    <time_frame>84-days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>fMRI Imaging</measure>
    <time_frame>84-days</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>DNS-3379 (0.5mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DNS-3379 (2.5mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DNS-3379</intervention_name>
    <description>DNS-3379</description>
    <arm_group_label>DNS-3379 (0.5mg)</arm_group_label>
    <arm_group_label>DNS-3379 (2.5mg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          -  Subjects who have experienced an ischemic stroke documented by CT or MRI resulting in
             upper extremity deficit that warrants the need for rehabilitation therapy.

          -  Medically stable subjects, with expected survival &gt; 12 months, who are able to be
             randomized to study drug beginning between 1 and 52 weeks (i.e., 7 to 365 days)
             post-stroke.

          -  Mild to moderately severe upper extremity motor impairment.

          -  mRS score of 1 to 4 from index stroke.

          -  Mini Mental State Examination (MMSE) score of â‰¥ 22.

        Main Exclusion Criteria:

          -  Residual motor deficit from any prior stroke

          -  Hemorrhagic stroke. Ischemic stroke with limited hemorrhagic conversion (i.e.,
             petechial hemorrhage or micro-hemorrhage) is acceptable.

          -  Severe or total sensory loss

          -  Moderate to severe aphasia and/or severe language deficits

          -  Excessive spasticity in the affected elbow or change in oral spasticity treatment
             drugs within 2 weeks before the Screening Visit

          -  Prior botulinum toxin injection to any portion of the affected arm in the prior 3
             months before the Screening Visit

          -  Major and active neurological, psychiatric, or medical diagnosis that is not
             adequately controlled and would likely reduce the safety of study participation or
             impact the subject's ability to comply with study protocol procedures in the opinion
             of the Investigator

          -  Any suicidal ideation during the subject's lifetime at any time prior to randomization
             including childhood (based on subject history), equivalent to type 2 on the
             Columbia-Suicide Severity Rating Scale (C-SSRS)

          -  Received an investigational pharmacotherapy therapy within the past 3 months

          -  Heavy use of any tobacco-smoke emitting products (including but not limited to
             cigarettes, pipes, and cigars) within 30 days of Baseline.

          -  Pregnant or lactating females
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New Lambton Heights</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunshine Coast University Hospital</name>
      <address>
        <city>Birtinya</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Repatriation General Hospital</name>
      <address>
        <city>Daw Park</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyell McEwin</name>
      <address>
        <city>Elizabeth Vale</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Vincents Melbourne</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Alfred</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Health</name>
      <address>
        <city>St Albans</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albury/Wodonga Hospital</name>
      <address>
        <city>Wodonga</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hollywood Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2017</study_first_submitted>
  <study_first_submitted_qc>August 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2017</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Ischemic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

